General Information of the Compound
Compound ID |
CP0136322
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-[2-[4-(5-chloro-2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]ethyl]-4-fluorobenzamide
Show/Hide
|
||||||||||||||||||
Synonyms |
59831-65-1
65Q28TV0ZY
AC1L23CG
AOB5520
C21H22ClFN4O2
CHEMBL245621
CTK8G0128
HALOPEMIDE
Halopemida
Halopemida [INN-Spanish]
Halopemide
Halopemide (USAN/INN)
Halopemide [USAN:INN]
Halopemide, >
Halopemide, 8
Halopemidum
Halopemidum [INN-Latin]
MLS003171133
MLS006012046
N-(2-(4-(5-Chloro-2-oxo-1-benzimidazolinyl)piperidino)ethyl)-p-fluorobenzamide
N-[2-[4-(5-Chloro-2-oxo-1-benzimidazolinyl)piperidino]ethyl]-p-fluorobenzamide
NSC 354856
R 34,301
R 34301
R-34301
SCHEMBL121267
UNII-65Q28TV0ZY
cid_65490
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C21H22ClFN4O2
|
||||||||||||||||||
Molecular Weight |
416.884
|
||||||||||||||||||
Canonical SMILES |
Fc1ccc(cc1)C(=O)NCCN1CCC(CC1)n1c2ccc(Cl)cc2[nH]c1=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C21H22ClFN4O2/c22-15-3-6-19-18(13-15)25-21(29)27(19)17-7-10-26(11-8-17)12-9-24-20(28)14-1-4-16(23)5-2-14/h1-6,13,17H,7-12H2,(H,24,28)(H,25,29)
Show/Hide
|
||||||||||||||||||
InChIKey |
NBHPRWLFLUBAIE-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
59831-65-1
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound